Categories AlphaGraphs, Earnings, Other Industries

Earnings: Owens Corning stock gains 1% on market-beating Q4 results

Shares of Owens Corning (OC) gained modestly during pre-market trading on Wednesday, after the company delivered better-than-expected fourth quarter net sales of $1.72 billion, up 7% year-over-year. Wall Street had expected the insulation and roofing company to report net sales of just $1.68 billion.

Image courtesy: Owens Corning

In Q4, the company swung to a profit of $1.55 per share from a loss of $0.04 per share in the year-over period. Excluding one-off items, earnings grew 24% to $1.38 per share, surpassing the Street consensus of $1.29 per share.

Fourth quarter adjusted EBIT stood at $228 million, compared to $215 million in the prior-year quarter.

OC shares gained 1% immediately following the announcement of the results. The stock has lost almost 37% of its value in the trailing 52 weeks, hurt by the general weakness in the home-improvement market.

An infographic on Owens Corning's fourth quarter 2018 earnings results

CEO Mike Thaman said, “Owens Corning had another record year in terms of revenue and adjusted EBIT, with all three businesses delivering double-digit EBIT margins. Today, Owens Corning is a more resilient and diversified company, better able to generate attractive returns for investors through the cycle.”

It may be noted that COO Brian Chambers will succeed Mike Thaman as the company’s CEO, effective April 18.

For full-year 2019, the Toledo, Ohio-based firm has guided capital additions of about $500 million, with an increased focus on productivity improvements. It also anticipates strong conversion of adjusted earnings into free cash flow during this period.

General corporate expenses are projected in the range of $140 million to $150 million.

 

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference, and much more!

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top